脑出血早发性癫痫的横断面研究及风险预测模型构建
该横断面研究连续纳入159例脑出血患者构建早发性癫痫预测模型(29例发生早发性癫痫,130例未发生),并另选77例急性脑出血患者(12例发生早发性癫痫,65例未发生)作为验证组。多因素Poisson回归显示糖尿病病程(RR=1.229,95%CI 1.065-1.896,P=0.036)、吸烟史(RR=1.419,95%CI 1.133-2.160,P=0.030)、脑梗死病史(RR=1.634,95%CI 1.128-2.548,P=0.041)、脑出血血肿量(RR=1.222,95%CI 1.024-2.052,P=0.041)和NES含量(RR=1.146,95%CI 1.041-1.704,P=0.032)为独立影响因素。模型转换为列线图形式的可视化优化评分量表。验证组中优化评分与AIS-PSS评分的截断值分别为144分和7分,优化评分的AUC和约登指数略低于AIS-PSS评分,但两者评估效能无显著差异(Z=1.874,P>0.05)。作者认为该优化评分便于临床使用且评估效能可靠。
要点
- 脑出血后早发性癫痫优化评分与AIS-PSS评分对早发性癫痫的评估效能无显著差异(Z=1.874,P>0.05)。
- 糖尿病病程(RR=1.229,95%CI 1.065-1.896,P=0.036)和吸烟史(RR=1.419,95%CI 1.133-2.160,P=0.030)是脑出血早发性癫痫的独立影响因素。
- 脑梗死病史(RR=1.634,95%CI 1.128-2.548,P=0.041)和脑出血血肿量(RR=1.222,95%CI 1.024-2.052,P=0.041)也是独立影响因素。
- NES含量(RR=1.146,95%CI 1.041-1.704,P=0.032)为独立影响因素,已纳入预测模型。
- 验证组中优化评分截断值为144分,AIS-PSS评分截断值为7分。
适用人群与场景
- 模型组:2021年1月至2021年8月连续纳入的159例脑出血患者,其中29例发生早发性癫痫,130例未发生继发性癫痫。
- 验证组:2021年8月至2022年2月的77例急性脑出血患者,其中12例发生早发性癫痫,65例未发生继发性癫痫。
诊断标准与关键阈值
- 优化评分截断值为144分,AIS-PSS评分截断值为7分。
- 预测模型纳入指标:糖尿病病程、吸烟史、脑梗死病史、脑出血血肿量、NES含量。
研究设计与关键结果
- 研究类型为横断面研究,模型组连续纳入159例脑出血患者(29例早发性癫痫 vs 130例无继发性癫痫),验证组77例急性脑出血患者(12例早发性癫痫 vs 65例无继发性癫痫)。
- 模型组中不同预后两组在糖尿病史、脑梗死病史、吸烟史、NIHSS评分、脑出血血肿量、SCr、NSE、S-100蛋白及脑出血部位等人口学特征方面差异均有统计学意义(均P<0.05)。
- 多因素Poisson回归显示糖尿病病程(RR=1.229,95%CI 1.065-1.896,P=0.036)、吸烟史(RR=1.419,95%CI 1.133-2.160,P=0.030)、脑梗死病史(RR=1.634,95%CI 1.128-2.548,P=0.041)、脑出血血肿量(RR=1.222,95%CI 1.024-2.052,P=0.041)、NES含量(RR=1.146,95%CI 1.041-1.704,P=0.032)为独立影响因素。
- 验证组中优化评分与AIS-PSS评分的截断值分别为144分和7分,优化评分的AUC和约登指数略低于AIS-PSS评分,但两者评估效能无显著差异(Z=1.874,P>0.05)。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,本研究构建了针对出血性卒中患者的早发性癫痫预测模型,并转化为便于临床使用的优化评分,其评估效能可靠。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To study the early-onset epilepsy of intracerebral hemorrhage and build a prediction model to evaluate its prediction efficiency.
METHODS: A cross-sectional investigation was conducted to construct a specialized optimized prediction model. The prediction model was converted into a visual optimized scoring scale, so as to quantify the probability of secondary epilepsy after intracerebral hemorrhage. Based on the current prediction model of acute cerebral infraction and post-stroke seizure (AIS-PSS), the evaluation efficacy of optimized score for secondary epilepsy after hemorrhagic stroke was explored.
RESULTS: (1) After sample size calculation and sufficient inclusion and exclusion, 159 patients with cerebral hemorrhage were continuously selected as the model group of this cross-sectional study. A total of 29 patients with early-onset epilepsy and 130 patients without secondary epilepsy were enrolled. The time span was from January 2021 to August 2021. In addition, 77 patients with acute cerebral hemorrhage from August 2021 to February 2022 were selected as the verification group, among which 12 patients had early-onset epilepsy and 65 patients had not any secondary epilepsy. (2) There were significant differences in demographic characteristics such as diabetes history, cerebral infarction history, smoking history, National Institutes of Health Stroke Scale (NIHSS) score, intracerebral hemorrhage hematoma volume, serum creatinine (SCr), neuron-specific enolase (NSE), S-100 protein and intracerebral hemorrhage site between the two model groups with different prognosis (all P < 0.05). (3) The above indexes were included in univariate and multivariate Poisson regression analysis, and the results showed that the duration of diabetes [relative risk (RR) = 1.229, 95% confidence interval (95%CI) was 1.065-1.896, P = 0.036], smoking history (RR = 1.419, 95%CI was 1.133-2.160, P = 0.030), history of cerebral infarction (RR = 1.634, 95%CI was 1.128-2.548, P = 0.041), hematoma volume of cerebral hemorrhage (RR = 1.222, 95%CI was 1.024-2.052, P = 0.041), NES content (RR = 1.146, 95%CI was 1.041-1.704, P = 0.032), were independent influencing factors to constitute the prediction model. The prediction model was converted into a visual optimized scoring scale in the form of a line diagram to obtain the prediction probability corresponding to the corresponding score. (4) Receiver operator characteristic curve (ROC curve) was used to test the evaluation efficiency of optimized score and AIS-PSS score for early-onset cerebral hemorrhage epilepsy. Relevant data of patients in the verification group were extracted according to the information of two scores, and the final score of each patient in the verification group was obtained. The score and prognosis were put into the ROC curve to evaluate the predictive ability of different prediction models. The results showed that the cut-off value of the optimized score and the AIS-PSS score were 144 points and 7 points, respectively, and the area under the ROC curve (AUC) and the Yoden index of the optimized score were slightly lower than the AIS-PSS score. However, compared with AIS-PSS score, there was no significant difference in the evaluation efficiency of optimized score for early-onset epilepsy (Z = 1.874, P > 0.05).
CONCLUSIONS: This study constructed a specific early-onset epilepsy prediction model for patients with hemorrhagic stroke, and transformed it into an optimized score that is easy for clinical use, and its evaluation efficiency is reliable.
参考来源
- Bai X, Zhang L, Li H, et al. [A cross-sectional study of early-onset epilepsy of intracerebral hemorrhage and construction of a risk prediction model]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567582. doi:10.3760/cma.j.cn121430-20221008-00878
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。